8-11755064-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001308093.3(GATA4):c.931A>G(p.Met311Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001308093.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Atrial septal defect 2 Pathogenic:1
- -
GATA4-related disorder Uncertain:1
The GATA4 c.928A>G variant is predicted to result in the amino acid substitution p.Met310Val. This variant was reported to segregate with disease in eight individuals affected with atrial septal defect or pulmonary stenosis (Chen et al. 2010. PubMed ID: 20347099). This variant has not been reported in a large population database, indicating this variant is rare. Additionally, another missense variant affecting this amino acid has been reported in a parent and two children with septal defects (Bu et al. 2021. PubMed ID: 33413087). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at